Pleurodesis for malignant pleural effusions: current controversies and variations in practices.

Pleurodesis for malignant pleural effusions: current controversies and variations in practices.

PURPOSE OF REVIEW: Malignant pleural effusions are common, and pleurodesis remains the best method to control re-accumulation of the pleural fluid. There are few randomized controlled trials studying the optimal management of malignant pleural effusions. A recent international survey of pleurodesis...

Bibliografske podrobnosti
Main Authors:	West, S, Davies, R, Lee, Y
Format:	Journal article
Jezik:	English
Izdano:	2004

Podobne knjige/članki

Pleurodesis for malignant pleural effusion: talc, toxicity and where next?
od: Davies, H, et al.
Izdano: (2008)

Chemical pleurodesis for malignant pleural effusion
od: W. Shouman, et al.
Izdano: (2012-07-01)

The outcome of Pleurodesis in Malignant Pleural Effusion
od: waleed M. hussen, et al.
Izdano: (2022-04-01)

Thoracoscopy and talc pleurodesis for malignant pleural effusions
od: Beatriz Romero, et al.
Izdano: (2024-10-01)

Pleurodesis practice for malignant pleural effusions in five English-speaking countries: survey of pulmonologists.
od: Lee, Y, et al.
Izdano: (2003)

Biological markers of successful pleurodesis for malignant pleural effusion
od: Psallidas, I, et al.
Izdano: (2016)

Usefulness of pigtail catheter in pleurodesis of malignant pleural effusion
od: Adel H.A. Ghoneim, et al.
Izdano: (2014-01-01)

Thoracoscopic tetracycline poudrage for pleurodesis in malignant pleural effusion
od: Magdy Khalil, et al.
Izdano: (2016-06-01)

Pleurodesis using different agents in malignant pleural effusion
od: Ramadan M. Bakr, et al.
Izdano: (2012-10-01)

Comparing cost of indwelling pleural catheter vs talc pleurodesis for malignant pleural effusion.
od: Penz, E, et al.
Izdano: (2014)

Management of Malignant Pleural Effusions with Indwelling Pleural Catheters or Talc Pleurodesis
od: Nadim Srour, et al.
Izdano: (2013-01-01)

Survival in patients with malignant pleural effusion undergoing talc pleurodesis
od: Hassan, M, et al.
Izdano: (2019)

Efficacy of tranexamic acid as pleurodesis agent in malignant pleural effusion
od: Eman A. Mohammed, et al.
Izdano: (2015-07-01)

Chemical pleurodesis for malignant pleural effusion: which agent is perfect?
od: Mohamed Elshabrawy Saleh, et al.
Izdano: (2020-05-01)

Malignant pleural effusion biomarkers as predictor for chemical pleurodesis success
od: Sherif Alsayed, et al.
Izdano: (2015-01-01)

Thoracic ultrasonography as a predictor of pleurodesis success in malignant pleural effusion
od: Corcoran, J, et al.
Izdano: (2017)

Thoracic ultrasound as an early predictor of pleurodesis success in malignant pleural effusion
od: Corcoran, J, et al.
Izdano: (2018)

Survival And Pleurodesis Response Markers In Malignant Pleural Effusion-The Promise Study
od: Psallidas, I, et al.
Izdano: (2018)

Echogenic swirling seen on ultrasound and outcome of pleurodesis in malignant pleural effusion
od: Hassan, M, et al.
Izdano: (2019)

Pleurodesis in the treatment of pneumothorax and pleural effusion
od: P.M. Rodríguez Suárez, et al.
Izdano: (2015-11-01)

Biological markers of favourable prognosis and successful pleurodesis for malignant pleural effusion
od: Psallidas, I, et al.
Izdano: (2016)

Pleural Space Elastance and Its Relation to Success Rates of Pleurodesis in Malignant Pleural Effusion
od: Hossam Hosny Masoud, et al.
Izdano: (2021-01-01)

Mitoxantrone pleurodesis to palliate malignant pleural effusion secondary to ovarian cancer
od: Valeri Rosalia, et al.
Izdano: (2004-09-01)

Predictors of talc slurry pleurodesis success in patients with malignant pleural effusions
od: P.S. Santos, et al.
Izdano: (2017-07-01)

Outcome of ultrasound-guided, single session pleurodesis in malignant pleural effusion
od: Khalil M. Magdy, et al.
Izdano: (2020-06-01)

Outcome of pleurodesis using different agents in management of malignant pleural effusion
od: Reham Mohammed El-Kolaly, et al.
Izdano: (2016-04-01)

The impact of repeated thoracentesis on the outcome of chemical pleurodesis in malignant pleural effusion
od: Adel Salah, et al.
Izdano: (2012-10-01)

THE ECONOMIC RATIONALE FOR THE USE OF OUTPATIENT PLEURODESIS IN THE TREATMENT OF MALIGNANT PLEURAL EFFUSIONS
od: O. V. Ivanov, et al.
Izdano: (2020-05-01)

Use of capsule tetracycline for pleurodesis in breast cancer patients with malignant pleural effusion
od: Emmanuel R Ezeome
Izdano: (2004-01-01)

Thoracoscopic evaluation of the effect of tumour burden on the outcome of pleurodesis in malignant pleural effusion
od: Ellayeh, M, et al.
Izdano: (2021)

Thoracoscopic evaluation of the effect of tumour burden on the outcome of pleurodesis in malignant pleural effusion
od: Ellayeh, MA, et al.
Izdano: (2021)

Modified indwelling pleural catheter versus silver nitrate pleurodesis for the management of malignant pleural effusion
od: Mohammed F Abdelghany, et al.
Izdano: (2022-01-01)

Pleural fluid CRP, LDH, and pH as predictors of successful pleurodesis in malignant pleural effusions
od: Samah M. Shehata, et al.
Izdano: (2015-07-01)

Use of lipoteichoic acid-T for pleurodesis in malignant pleural effusion: a phase I toxicity and dose-escalation study.
od: Rahman, N, et al.
Izdano: (2008)

Long-term results of pleurodesis in malignant pleural effusions: Doxycycline vs Bleomycin
od: Rahmatollah Rafiei, et al.
Izdano: (2014-01-01)

Efficacy and safety profile of autologous blood tetracycline pleurodesis for malignant pleural effusion
od: Warangkana Keeratichananont, et al.
Izdano: (2015-04-01)

Efficacy and safety of talc pleurodesis for malignant pleural effusion: a meta-analysis.
od: Huan Xia, et al.
Izdano: (2014-01-01)

Results of chemical pleurodesis with mitoxantrone in malignant pleural effusion from breast cancer
od: Tsilikas Christodoulos, et al.
Izdano: (2004-05-01)

Talc pleurodesis in the management of persistent pleural effusion in an infant
od: Ali Özdemir, et al.
Izdano: (2016-06-01)

Talc pleurodesis in the management of persistent pleural effusion in an infant
od: Ali Ozdemir, et al.
Izdano: (2016-06-01)